nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00316	0.202	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—SLC2A6—testicular cancer	0.00228	0.146	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00143	0.0918	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00123	0.0789	CbGpPWpGaD
Valaciclovir—Decreased appetite—Cisplatin—testicular cancer	0.0012	0.00122	CcSEcCtD
Valaciclovir—Bronchitis—Epirubicin—testicular cancer	0.0012	0.00122	CcSEcCtD
Valaciclovir—Diarrhoea—Dactinomycin—testicular cancer	0.0012	0.00122	CcSEcCtD
Valaciclovir—Nasopharyngitis—Doxorubicin—testicular cancer	0.0012	0.00122	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Cisplatin—testicular cancer	0.0012	0.00121	CcSEcCtD
Valaciclovir—Vomiting—Bleomycin—testicular cancer	0.00119	0.00121	CcSEcCtD
Valaciclovir—Depression—Methotrexate—testicular cancer	0.00119	0.00121	CcSEcCtD
Valaciclovir—Rash—Bleomycin—testicular cancer	0.00118	0.0012	CcSEcCtD
Valaciclovir—Pain—Cisplatin—testicular cancer	0.00118	0.0012	CcSEcCtD
Valaciclovir—Dermatitis—Bleomycin—testicular cancer	0.00118	0.0012	CcSEcCtD
Valaciclovir—Hypersensitivity—Ifosfamide—testicular cancer	0.00118	0.0012	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00118	0.0012	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—testicular cancer	0.00117	0.00119	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00116	0.00118	CcSEcCtD
Valaciclovir—Stomatitis—Methotrexate—testicular cancer	0.00116	0.00118	CcSEcCtD
Valaciclovir—Influenza—Doxorubicin—testicular cancer	0.00116	0.00118	CcSEcCtD
Valaciclovir—Asthenia—Ifosfamide—testicular cancer	0.00115	0.00117	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Epirubicin—testicular cancer	0.00114	0.00116	CcSEcCtD
Valaciclovir—Feeling abnormal—Cisplatin—testicular cancer	0.00114	0.00116	CcSEcCtD
Valaciclovir—Paraesthesia—Etoposide—testicular cancer	0.00114	0.00116	CcSEcCtD
Valaciclovir—Pruritus—Ifosfamide—testicular cancer	0.00114	0.00115	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—testicular cancer	0.00114	0.00115	CcSEcCtD
Valaciclovir—Dyspnoea—Etoposide—testicular cancer	0.00113	0.00115	CcSEcCtD
Valaciclovir—Somnolence—Etoposide—testicular cancer	0.00113	0.00115	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—testicular cancer	0.00113	0.00114	CcSEcCtD
Valaciclovir—Nausea—Bleomycin—testicular cancer	0.00112	0.00113	CcSEcCtD
Valaciclovir—Vomiting—Dactinomycin—testicular cancer	0.00111	0.00113	CcSEcCtD
Valaciclovir—Bronchitis—Doxorubicin—testicular cancer	0.00111	0.00113	CcSEcCtD
Valaciclovir—Rash—Dactinomycin—testicular cancer	0.00111	0.00112	CcSEcCtD
Valaciclovir—Decreased appetite—Etoposide—testicular cancer	0.0011	0.00112	CcSEcCtD
Valaciclovir—Diarrhoea—Ifosfamide—testicular cancer	0.0011	0.00112	CcSEcCtD
Valaciclovir—Renal failure—Epirubicin—testicular cancer	0.0011	0.00111	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Etoposide—testicular cancer	0.0011	0.00111	CcSEcCtD
Valaciclovir—Body temperature increased—Cisplatin—testicular cancer	0.00109	0.00111	CcSEcCtD
Valaciclovir—Fatigue—Etoposide—testicular cancer	0.00109	0.00111	CcSEcCtD
Valaciclovir—Stomatitis—Epirubicin—testicular cancer	0.00109	0.0011	CcSEcCtD
Valaciclovir—Pain—Etoposide—testicular cancer	0.00108	0.0011	CcSEcCtD
Valaciclovir—Constipation—Etoposide—testicular cancer	0.00108	0.0011	CcSEcCtD
Valaciclovir—Urinary tract infection—Epirubicin—testicular cancer	0.00108	0.0011	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00108	0.00109	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—testicular cancer	0.00107	0.00109	CcSEcCtD
Valaciclovir—Haematuria—Epirubicin—testicular cancer	0.00106	0.00108	CcSEcCtD
Valaciclovir—Dizziness—Ifosfamide—testicular cancer	0.00106	0.00108	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—testicular cancer	0.00106	0.00108	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—testicular cancer	0.00106	0.00107	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00106	0.00107	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Epirubicin—testicular cancer	0.00105	0.00107	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—testicular cancer	0.00105	0.00106	CcSEcCtD
Valaciclovir—Sinusitis—Epirubicin—testicular cancer	0.00105	0.00106	CcSEcCtD
Valaciclovir—Feeling abnormal—Etoposide—testicular cancer	0.00105	0.00106	CcSEcCtD
Valaciclovir—Nausea—Dactinomycin—testicular cancer	0.00104	0.00106	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Etoposide—testicular cancer	0.00104	0.00105	CcSEcCtD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00103	0.0658	CbGpPWpGaD
Valaciclovir—Vomiting—Ifosfamide—testicular cancer	0.00102	0.00104	CcSEcCtD
Valaciclovir—Hypersensitivity—Cisplatin—testicular cancer	0.00102	0.00104	CcSEcCtD
Valaciclovir—Renal failure—Doxorubicin—testicular cancer	0.00101	0.00103	CcSEcCtD
Valaciclovir—Rash—Ifosfamide—testicular cancer	0.00101	0.00103	CcSEcCtD
Valaciclovir—Dermatitis—Ifosfamide—testicular cancer	0.00101	0.00103	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—testicular cancer	0.00101	0.00103	CcSEcCtD
Valaciclovir—Urticaria—Etoposide—testicular cancer	0.00101	0.00102	CcSEcCtD
Valaciclovir—Stomatitis—Doxorubicin—testicular cancer	0.00101	0.00102	CcSEcCtD
Valaciclovir—Rhinitis—Epirubicin—testicular cancer	0.001	0.00102	CcSEcCtD
Valaciclovir—Abdominal pain—Etoposide—testicular cancer	0.001	0.00102	CcSEcCtD
Valaciclovir—Body temperature increased—Etoposide—testicular cancer	0.001	0.00102	CcSEcCtD
Valaciclovir—Urinary tract infection—Doxorubicin—testicular cancer	0.001	0.00102	CcSEcCtD
Valaciclovir—Hepatitis—Epirubicin—testicular cancer	0.001	0.00102	CcSEcCtD
Valaciclovir—Asthenia—Cisplatin—testicular cancer	0.000993	0.00101	CcSEcCtD
Valaciclovir—Pharyngitis—Epirubicin—testicular cancer	0.000993	0.00101	CcSEcCtD
Valaciclovir—Urinary tract disorder—Epirubicin—testicular cancer	0.000988	0.001	CcSEcCtD
Valaciclovir—Oedema peripheral—Epirubicin—testicular cancer	0.000986	0.001	CcSEcCtD
Valaciclovir—Haematuria—Doxorubicin—testicular cancer	0.000984	0.000999	CcSEcCtD
Valaciclovir—Urethral disorder—Epirubicin—testicular cancer	0.000981	0.000997	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000976	0.000991	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—testicular cancer	0.000968	0.000983	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—testicular cancer	0.000966	0.000981	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—testicular cancer	0.000964	0.000979	CcSEcCtD
Valaciclovir—Chills—Methotrexate—testicular cancer	0.00096	0.000975	CcSEcCtD
Valaciclovir—Nausea—Ifosfamide—testicular cancer	0.000954	0.000969	CcSEcCtD
Valaciclovir—Diarrhoea—Cisplatin—testicular cancer	0.000947	0.000962	CcSEcCtD
Valaciclovir—Erythema multiforme—Epirubicin—testicular cancer	0.000946	0.000961	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—testicular cancer	0.000945	0.00096	CcSEcCtD
Valaciclovir—Hypersensitivity—Etoposide—testicular cancer	0.000935	0.000949	CcSEcCtD
Valaciclovir—Rhinitis—Doxorubicin—testicular cancer	0.000928	0.000943	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—testicular cancer	0.000926	0.000941	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—testicular cancer	0.000919	0.000934	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—testicular cancer	0.000915	0.000929	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—testicular cancer	0.000912	0.000927	CcSEcCtD
Valaciclovir—Asthenia—Etoposide—testicular cancer	0.00091	0.000925	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—testicular cancer	0.000908	0.000922	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000907	0.0581	CbGpPWpGaD
Valaciclovir—Immune system disorder—Epirubicin—testicular cancer	0.000904	0.000918	CcSEcCtD
Valaciclovir—Mediastinal disorder—Epirubicin—testicular cancer	0.000902	0.000916	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—testicular cancer	0.000901	0.000915	CcSEcCtD
Valaciclovir—Chills—Epirubicin—testicular cancer	0.000898	0.000912	CcSEcCtD
Valaciclovir—Pruritus—Etoposide—testicular cancer	0.000897	0.000912	CcSEcCtD
Valaciclovir—Alopecia—Epirubicin—testicular cancer	0.000884	0.000898	CcSEcCtD
Valaciclovir—Vomiting—Cisplatin—testicular cancer	0.00088	0.000894	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—testicular cancer	0.000876	0.000889	CcSEcCtD
Valaciclovir—Rash—Cisplatin—testicular cancer	0.000873	0.000887	CcSEcCtD
Valaciclovir—Dermatitis—Cisplatin—testicular cancer	0.000872	0.000886	CcSEcCtD
Valaciclovir—Diarrhoea—Etoposide—testicular cancer	0.000868	0.000882	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—testicular cancer	0.00086	0.000874	CcSEcCtD
Valaciclovir—Flatulence—Epirubicin—testicular cancer	0.000858	0.000872	CcSEcCtD
Valaciclovir—Tension—Epirubicin—testicular cancer	0.000855	0.000869	CcSEcCtD
Valaciclovir—Nervousness—Epirubicin—testicular cancer	0.000846	0.00086	CcSEcCtD
Valaciclovir—Back pain—Epirubicin—testicular cancer	0.000843	0.000856	CcSEcCtD
Valaciclovir—Dizziness—Etoposide—testicular cancer	0.000839	0.000852	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—testicular cancer	0.000836	0.00085	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—testicular cancer	0.000835	0.000848	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—testicular cancer	0.000833	0.000847	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—testicular cancer	0.000831	0.000844	CcSEcCtD
Valaciclovir—Nausea—Cisplatin—testicular cancer	0.000822	0.000835	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—testicular cancer	0.000818	0.000831	CcSEcCtD
Valaciclovir—Cough—Methotrexate—testicular cancer	0.000812	0.000825	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—testicular cancer	0.000807	0.000819	CcSEcCtD
Valaciclovir—Vomiting—Etoposide—testicular cancer	0.000807	0.000819	CcSEcCtD
Valaciclovir—Anaemia—Epirubicin—testicular cancer	0.000805	0.000818	CcSEcCtD
Valaciclovir—Agitation—Epirubicin—testicular cancer	0.000801	0.000813	CcSEcCtD
Valaciclovir—Rash—Etoposide—testicular cancer	0.0008	0.000812	CcSEcCtD
Valaciclovir—Dermatitis—Etoposide—testicular cancer	0.000799	0.000812	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000797	0.051	CbGpPWpGaD
Valaciclovir—Headache—Etoposide—testicular cancer	0.000795	0.000807	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—testicular cancer	0.000794	0.000807	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—testicular cancer	0.000793	0.000805	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—testicular cancer	0.000793	0.000805	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—testicular cancer	0.000793	0.000805	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—testicular cancer	0.000791	0.000804	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000787	0.0008	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—testicular cancer	0.000783	0.000795	CcSEcCtD
Valaciclovir—Leukopenia—Epirubicin—testicular cancer	0.00078	0.000792	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—testicular cancer	0.00078	0.000792	CcSEcCtD
Valaciclovir—Confusional state—Methotrexate—testicular cancer	0.000766	0.000778	CcSEcCtD
Valaciclovir—Cough—Epirubicin—testicular cancer	0.00076	0.000772	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—testicular cancer	0.00076	0.000772	CcSEcCtD
Valaciclovir—Convulsion—Epirubicin—testicular cancer	0.000755	0.000767	CcSEcCtD
Valaciclovir—Infection—Methotrexate—testicular cancer	0.000755	0.000767	CcSEcCtD
Valaciclovir—Nausea—Etoposide—testicular cancer	0.000753	0.000765	CcSEcCtD
Valaciclovir—Hypertension—Epirubicin—testicular cancer	0.000752	0.000764	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—testicular cancer	0.000745	0.000757	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—testicular cancer	0.000745	0.000757	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—testicular cancer	0.000744	0.000756	CcSEcCtD
Valaciclovir—Arthralgia—Epirubicin—testicular cancer	0.000742	0.000753	CcSEcCtD
Valaciclovir—Chest pain—Epirubicin—testicular cancer	0.000742	0.000753	CcSEcCtD
Valaciclovir—Myalgia—Epirubicin—testicular cancer	0.000742	0.000753	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—testicular cancer	0.000741	0.000753	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—testicular cancer	0.000738	0.00075	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000737	0.000748	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000729	0.0467	CbGpPWpGaD
Valaciclovir—Dry mouth—Epirubicin—testicular cancer	0.000725	0.000737	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—testicular cancer	0.000724	0.000736	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—testicular cancer	0.000722	0.000733	CcSEcCtD
Valaciclovir—Confusional state—Epirubicin—testicular cancer	0.000717	0.000728	CcSEcCtD
Valaciclovir—Anaphylactic shock—Epirubicin—testicular cancer	0.000711	0.000722	CcSEcCtD
Valaciclovir—Oedema—Epirubicin—testicular cancer	0.000711	0.000722	CcSEcCtD
Valaciclovir—Infection—Epirubicin—testicular cancer	0.000706	0.000718	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—testicular cancer	0.000703	0.000715	CcSEcCtD
Valaciclovir—Convulsion—Doxorubicin—testicular cancer	0.000698	0.00071	CcSEcCtD
Valaciclovir—Nervous system disorder—Epirubicin—testicular cancer	0.000697	0.000708	CcSEcCtD
Valaciclovir—Thrombocytopenia—Epirubicin—testicular cancer	0.000696	0.000707	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—testicular cancer	0.000696	0.000707	CcSEcCtD
Valaciclovir—Tachycardia—Epirubicin—testicular cancer	0.000694	0.000705	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000692	0.000703	CcSEcCtD
Valaciclovir—Skin disorder—Epirubicin—testicular cancer	0.000691	0.000702	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—testicular cancer	0.000687	0.000698	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—testicular cancer	0.000686	0.000697	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—testicular cancer	0.000686	0.000697	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—testicular cancer	0.000686	0.000697	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—testicular cancer	0.000682	0.000693	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000682	0.000692	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000678	0.0434	CbGpPWpGaD
Valaciclovir—Anorexia—Epirubicin—testicular cancer	0.000678	0.000689	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—testicular cancer	0.000677	0.000688	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—testicular cancer	0.000675	0.000686	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—testicular cancer	0.000671	0.000682	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—testicular cancer	0.000669	0.000679	CcSEcCtD
Valaciclovir—Confusional state—Doxorubicin—testicular cancer	0.000663	0.000674	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—testicular cancer	0.00066	0.000671	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—testicular cancer	0.000658	0.000668	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—testicular cancer	0.000658	0.000668	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000656	0.000666	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—testicular cancer	0.000655	0.000665	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—testicular cancer	0.000654	0.000664	CcSEcCtD
Valaciclovir—Pain—Methotrexate—testicular cancer	0.00065	0.00066	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000648	0.000658	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—testicular cancer	0.000645	0.000655	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—testicular cancer	0.000644	0.000654	CcSEcCtD
Valaciclovir—Insomnia—Epirubicin—testicular cancer	0.000643	0.000653	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—testicular cancer	0.000642	0.000652	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—testicular cancer	0.000639	0.000649	CcSEcCtD
Valaciclovir—Paraesthesia—Epirubicin—testicular cancer	0.000638	0.000649	CcSEcCtD
Valaciclovir—Dyspnoea—Epirubicin—testicular cancer	0.000634	0.000644	CcSEcCtD
Valaciclovir—Somnolence—Epirubicin—testicular cancer	0.000632	0.000642	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000629	0.0403	CbGpPWpGaD
Valaciclovir—Anorexia—Doxorubicin—testicular cancer	0.000627	0.000637	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—testicular cancer	0.000626	0.000636	CcSEcCtD
Valaciclovir—Dyspepsia—Epirubicin—testicular cancer	0.000626	0.000636	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—testicular cancer	0.000621	0.000631	CcSEcCtD
Valaciclovir—Decreased appetite—Epirubicin—testicular cancer	0.000618	0.000628	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000614	0.000624	CcSEcCtD
Valaciclovir—Fatigue—Epirubicin—testicular cancer	0.000613	0.000623	CcSEcCtD
Valaciclovir—Pain—Epirubicin—testicular cancer	0.000608	0.000618	CcSEcCtD
Valaciclovir—Constipation—Epirubicin—testicular cancer	0.000608	0.000618	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—testicular cancer	0.000604	0.000613	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—testicular cancer	0.000601	0.00061	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—testicular cancer	0.000601	0.00061	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000599	0.000609	CcSEcCtD
Valaciclovir—Insomnia—Doxorubicin—testicular cancer	0.000595	0.000604	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—testicular cancer	0.000591	0.0006	CcSEcCtD
Valaciclovir—Dyspnoea—Doxorubicin—testicular cancer	0.000587	0.000596	CcSEcCtD
Valaciclovir—Feeling abnormal—Epirubicin—testicular cancer	0.000586	0.000595	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—testicular cancer	0.000585	0.000594	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000581	0.000591	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—testicular cancer	0.000579	0.000588	CcSEcCtD
Valaciclovir—Decreased appetite—Doxorubicin—testicular cancer	0.000572	0.000581	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000568	0.000577	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—testicular cancer	0.000567	0.000576	CcSEcCtD
Valaciclovir—Urticaria—Epirubicin—testicular cancer	0.000565	0.000574	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—testicular cancer	0.000563	0.000572	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—testicular cancer	0.000563	0.000572	CcSEcCtD
Valaciclovir—Abdominal pain—Epirubicin—testicular cancer	0.000562	0.000571	CcSEcCtD
Valaciclovir—Body temperature increased—Epirubicin—testicular cancer	0.000562	0.000571	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00056	0.0358	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Methotrexate—testicular cancer	0.00056	0.000569	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—testicular cancer	0.000545	0.000554	CcSEcCtD
Valaciclovir—Feeling abnormal—Doxorubicin—testicular cancer	0.000542	0.000551	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000538	0.000547	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—testicular cancer	0.000538	0.000546	CcSEcCtD
Valaciclovir—Hypersensitivity—Epirubicin—testicular cancer	0.000524	0.000532	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—testicular cancer	0.000523	0.000531	CcSEcCtD
Valaciclovir—Body temperature increased—Doxorubicin—testicular cancer	0.00052	0.000528	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—testicular cancer	0.00052	0.000528	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—testicular cancer	0.00052	0.000528	CcSEcCtD
Valaciclovir—Asthenia—Epirubicin—testicular cancer	0.00051	0.000518	CcSEcCtD
Valaciclovir—Pruritus—Epirubicin—testicular cancer	0.000503	0.000511	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—testicular cancer	0.000502	0.00051	CcSEcCtD
Valaciclovir—Diarrhoea—Epirubicin—testicular cancer	0.000487	0.000494	CcSEcCtD
Valaciclovir—Hypersensitivity—Doxorubicin—testicular cancer	0.000485	0.000492	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—testicular cancer	0.000483	0.000491	CcSEcCtD
Valaciclovir—Rash—Methotrexate—testicular cancer	0.000479	0.000487	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—testicular cancer	0.000479	0.000486	CcSEcCtD
Valaciclovir—Headache—Methotrexate—testicular cancer	0.000476	0.000484	CcSEcCtD
Valaciclovir—Asthenia—Doxorubicin—testicular cancer	0.000472	0.00048	CcSEcCtD
Valaciclovir—Dizziness—Epirubicin—testicular cancer	0.00047	0.000478	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000467	0.0299	CbGpPWpGaD
Valaciclovir—Pruritus—Doxorubicin—testicular cancer	0.000465	0.000473	CcSEcCtD
Valaciclovir—Vomiting—Epirubicin—testicular cancer	0.000452	0.000459	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—testicular cancer	0.000451	0.000458	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—testicular cancer	0.00045	0.000457	CcSEcCtD
Valaciclovir—Rash—Epirubicin—testicular cancer	0.000448	0.000455	CcSEcCtD
Valaciclovir—Dermatitis—Epirubicin—testicular cancer	0.000448	0.000455	CcSEcCtD
Valaciclovir—Headache—Epirubicin—testicular cancer	0.000445	0.000453	CcSEcCtD
Valaciclovir—Dizziness—Doxorubicin—testicular cancer	0.000435	0.000442	CcSEcCtD
Valaciclovir—Nausea—Epirubicin—testicular cancer	0.000422	0.000429	CcSEcCtD
Valaciclovir—Vomiting—Doxorubicin—testicular cancer	0.000418	0.000425	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—testicular cancer	0.000415	0.000421	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—testicular cancer	0.000414	0.000421	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—testicular cancer	0.000412	0.000419	CcSEcCtD
Valaciclovir—Nausea—Doxorubicin—testicular cancer	0.000391	0.000397	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000345	0.0221	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00032	0.0205	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000304	0.0195	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000284	0.0182	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000237	0.0152	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HPGDS—testicular cancer	0.000135	0.00867	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—STK11—testicular cancer	9.84e-05	0.0063	CbGpPWpGaD
